Clinical Drug Experience Knowledgebase

Acute Disease (Phase 1)

Adenocarcinoma (Phase 2)

Adenocarcinoma, Mucinous (Phase 2)

Bone Neoplasms (Phase 1)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Signet Ring Cell (Phase 2)

Colonic Neoplasms (Phase 1)

Cystadenocarcinoma (Phase 2)

Genital Neoplasms, Female (Phase 1)

Genital Neoplasms, Male (Phase 1)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Gliosarcoma (Phase 2)

Graft vs Host Disease (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Lip Neoplasms (Phase 1)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Multiple Myeloma (Phase 2)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 2)

Osteosarcoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 3)

Skin Neoplasms (Phase 1)

Thyroid Neoplasms (Phase 1)

Urologic Neoplasms (Phase 1)